Evidence map›Paper›PMID 41273880›Full record

ArticleTuberculosis (Edinburgh, Scotland)2025

CountFU: Ditching CFUs for qPCR enumeration of Mycobacterium tuberculosis and a call to join the revolution.

Jason D Limberis, Alina Nalyvayko, Alexander Mohapatra, Rania Bouzeyen, Zach Howard, Weihao Zheng, John Z Metcalfe

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jason D LimberisDivision of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Centre, University of California, San Francisco, San Francisco, CA, USA. Electronic address: Jason.Limberis@ucsf.edu.
Alina NalyvaykoDivision of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Centre, University of California, San Francisco, San Francisco, CA, USA.
Alexander MohapatraDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
Rania BouzeyenDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
Zach HowardDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
Weihao ZhengDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
John Z MetcalfeDivision of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Centre, University of California, San Francisco, San Francisco, CA, USA.

Funding

UCSF-UCB Tuberculosis Research Advancement Center (TRAC)P30AI168440 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFERY S COX, PAYAM NAHID · 2022 to 2026
$5.8M
Tuberculosis Research and Mentorship Program (TB RAMP II)R25AI147375 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Elizabeth Fair, PAYAM NAHID · 2020 to 2026
$2.8M
Comprehensive characterization of Rv0678 bedaquiline resistance-conferring polymorphismsR21AI180963 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI METCALFE, JOHN ZAPATA · 2024 to 2025
$450k
NIAID NIH HHS P30 AI168440NIAID NIH HHS R21 AI180963NIAID NIH HHS R25 AI147375
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41273880
PMCPMC13156875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.